Key elements of psoriasis immunogenetics: A review
Psoriasis is one of the most common skin diseases, affecting 2% to 3% of the world population. It occurs at any stage of life. “Early” psoriasis or type I manifests before 40 years, and “late” psoriasis or type II, after 40 years. It has a strong genetic basis and the probability of inheriting the d...
Main Authors: | Duque Cardona, Leidy Yohana, Sotelo Tascón, Jared, Velásquez Lopera, Margarita María |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Universidad de Antioquia
2014-10-01
|
Series: | Iatreia |
Subjects: | |
Online Access: | http://aprendeenlinea.udea.edu.co/revistas/index.php/iatreia/article/view/17323/17397 |
Similar Items
-
IL-17 – UM NOVO ALVO TERAPÊUTICO NA PSORÍASE
by: Tiago Torres, et al.
Published: (2014-10-01) -
Evaluation of the antitumor activity of interleukin-12 in an experimental murine model of colorectal cancer induced by 1,2 dimethylhydrazine (DMH) Estudio de la respuesta antitumoral de la interleucina-12 en cáncer de colon inducido mediante 1,2-dimetilhidracina (DMH)
by: S. Coca, et al.
Published: (2005-09-01) -
Biological therapies in psoriasis - revisited
by: Sârbu Maria-Isabela, et al.
Published: (2018-06-01) -
T helper type 17 in psoriasis: From basic immunology to clinical practice
by: Hsien-Yi Chiu, et al.
Published: (2012-12-01) -
Produção deficiente de citocinas Th1 em camundongos BALB/c jovens
by: A.C. Pelizon, et al.
Published: (2007-05-01)